Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
This is a 40% decrease from the number of companies inspected in the previous quarter, when 10 companies received 10 inspections.
Most of the companies inspected at the time were involved in the Drugs sector. Both the Devices and Food and Cosmetics sectors sectors tied for second most common type.
There were three companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Catalent Pharma Solutions, LLC | Drugs | 02/01/2023 | No Action Indicated (NAI) |
Cepham, Inc. | Food and Cosmetics | 02/28/2023 | No Action Indicated (NAI) |
Janssen Research & Development | Drugs | 03/01/2023 | No Action Indicated (NAI) |
Micro Stamping Corporation | Devices | 01/18/2023 | Voluntary Action Indicated (VAI) |
Novel Laboratories, Inc. | Drugs | 01/13/2023 | Voluntary Action Indicated (VAI) |
SOFIE Company | Drugs | 01/20/2023 | Voluntary Action Indicated (VAI) |